<DOC>
	<DOCNO>NCT01168830</DOCNO>
	<brief_summary>First Man Trial drug elute absorbable metal scaffold . To assess safety</brief_summary>
	<brief_title>First Man Trial - BIOSOLVE-I</brief_title>
	<detailed_description />
	<criteria>Patient &gt; 18 year &lt; 80 year age Written patient inform consent available prior PCI Patients stable unstable angina pectoris document silent ischemia Patient eligible PCI Patient acceptable candidate coronary artery bypass surgery Left ventricular ejection fraction &lt; 30 % Presence visible thrombus target vessel visualize angiography Lesion and/or way lesion extremely calcify ( e.g . IVUS catheter reach/cross lesion ) Patients threevessel three vessel require treatment Patients previous CABG target vessel ( ) Patients know coronary artery spasm Myocardial infarction ( STEMI/NSTEMI ) within 4 week intend treatment . Determination CKMB and/or troponin T I require . Patients plan major surgery within 12 month coronary intervention Patients risk either acetylsalicylic acid , clopidogrel Prasugrel cessation Patients current Phenprocoumon Cumarine therapy Impaired renal function ( serum creatinine &gt; 2.0mg/dl 177micromol/l , determine within 72 hour prior intervention ) Additional coronary lesion ( restenotic de novo ) vessel require treatment Totally occlude coronary artery ( TIMI flow 0 ) Lesions locate within arterial venous graft Ostial lesion Previous and/or plan brachytherapy target vessel Target lesion locate leave main coronary artery Stroke TIA &lt; 6 month prior procedure Patient sign cardiogenic shock Surgeries kind within 30 day prior screen Patient bleed diathesis anticoagulation antiplatelet medication contraindicate Pregnant and/or breastfeed female female intend become pregnant Patient currently enrol investigational device drug trial Patient expect incompliance medical ( antiplatelet , anticoagulation ) therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>